Oman International Hospital in Muscat, Oman

The Idealmed Global Healthcare Services (Idealmed GHS),  part of the european  health group IGHS, based in Coimbra, Portugal, starts the comissioning of the impressive “Oman International Hospital”.

Having participated in projects in Asia, Europe, Africa and in the Midle East, the extraordinary recently launched “Oman International Hospital” (OIH), is the perfect example of the Idealmed GHS capabilities. The OIH was fully conceived, designed and equipped by Idealmed GHS, that will now operate the Hospital in accordance with the most exigent international standards of quality.

With matchless conditions, the “Oman International Hospital” is already considered a landmark in Oman and assumes the ambition to lead the private health sector in the country and in the region, by providing the most advanced diagnostic and treatment solutions to all its users.

As per vision of the Idealmed GHS, the OIH also hosts a “Med Academy”, fully sustained by Siemens, that will ensure the continous training of all its Human Resources and the implementation of international programmes that promotes the sharing of competences and experiences.

Idealmed GHS integrates the international know-how of the most distinguished organizations, from Universities to R&D Institutions, leading multinacional companies, and other renowned hospital groups worldwide, with the single aim to conceive, develop and operate unique health projects, allowing its partners to have a single entity fully responsible for its implementation and governance.

Idealmed GHS assumes its international linkage with companies like Siemens, IBM, among many others, and the relation with the Academic world, in particular with the University of Coimbra, one of the oldest and most prestigious International Universities, as its key pillars of success.

“Knowing that in a modern world knowledge has no boundaries, at Idealmed GHS we merge the experience of all our partners, crafting healthcare projects and tailoring services to each individual.

“In all our facilities, we integrate culture with science, safety with confort, and aesthetics with functionality. Using the most innovative layouts and engeneering concepts and leading-edge eqquipment solutions, we combine techonlogical sophostication with the know-how of the most skilled and trained Human Resources.

“At Idealmed GHS we assume a disruptive vision for hospitals, leading innovative projects and  maximizing their sustainability and profitability, enhancing the confort and well-being of its users and surpassing their superlative expectations,” stated Dr. José Alexandre Cunha, Chairman Of Idealmed GHS.

“Crafting healthcare projects, tailoring services to each individual.”

“Toghether we do it better.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version